Alice Blue’s referral scheme quickly becomes a huge hit with new consumers.

The referral program has been a successful initiative in new customer initiatives. With the target to acquire 2L customers by the end of 2022, we have renewed our focus on value addition to traders and investors

Advertisement


Bangalore (Karnataka) [India] : Alice Blue, a reputed discount stock broker company has witnessed a phenomenal increase in revenues and new customers with its unique referral program gaining popularity among investors.

Sidhavelayutham, CEO, of Alice Blue said, “The referral program has been a successful initiative in new customer initiatives. With the target to acquire 2L customers by the end of 2022, we have renewed our focus on value addition to traders and investors. We ensure ongoing technological upgrades for trading tools to reduce downtime and service glitches and also by offering a variety of access tools and strategies & learning courses.”

Significantly, even during volatility in the markets Alice Blue has witnessed a growing customer addition indicating a high positivity in Investments and trading as a whole. With the growth of economic activity investors have seen a rise in their earnings & investments prompting them to refer their family and friends to invest as well.

Alice Blue gives 500 on every referral a customer provides. Additionally, the customer gets 10% of the brokerage of their friend pays for life, and they receive 10% cashback on brokerage for 30 days as well. Additionally, the company offered a premium course on options trading worth 1500 for free for both new and existing clients as a referral bonus.

Sidhavelayutham, further said, “The current period is highly crucial in terms of investment, as the market’s decline is creating possibilities to invest in particular areas at significantly reduced prices.”

 

Log in to https://aliceblueonline.com/ to learn more about the various investment opportunities available, as well as their educational content on the Stock Market.

 

Advertisement